126 related articles for article (PubMed ID: 36754744)
1. Swedish Snuff (Snus), Cigarette Smoking, and Risk of Type 2 Diabetes.
Titova OE; Baron JA; Fall T; Michaëlsson K; Larsson SC
Am J Prev Med; 2023 Jul; 65(1):60-66. PubMed ID: 36754744
[TBL] [Abstract][Full Text] [Related]
2. Swedish snuff (snus) dipping, cigarette smoking, and risk of peripheral artery disease: a prospective cohort study.
Yuan S; Titova OE; Damrauer SM; Åkesson A; Larsson SC
Sci Rep; 2022 Jul; 12(1):12139. PubMed ID: 35840660
[TBL] [Abstract][Full Text] [Related]
3. Swedish snuff (snus) and risk of cardiovascular disease and mortality: prospective cohort study of middle-aged and older individuals.
Titova OE; Baron JA; Michaëlsson K; Larsson SC
BMC Med; 2021 May; 19(1):111. PubMed ID: 33957912
[TBL] [Abstract][Full Text] [Related]
4. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men.
Östenson CG; Hilding A; Grill V; Efendic S
Scand J Public Health; 2012 Dec; 40(8):730-7. PubMed ID: 23117209
[TBL] [Abstract][Full Text] [Related]
5. Association of snus experimentation in late adolescence with daily cigarette smoking in early adulthood: A longitudinal study among Finnish men.
Araneda D; Korhonen T; Laatikainen T; Haukkala A; Rose RJ; Kaprio J
Scand J Public Health; 2020 Aug; 48(6):638-645. PubMed ID: 30973058
[No Abstract] [Full Text] [Related]
6. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts.
Carlsson S; Andersson T; Araghi M; Galanti R; Lager A; Lundberg M; Nilsson P; Norberg M; Pedersen NL; Trolle-Lagerros Y; Magnusson C
J Intern Med; 2017 Apr; 281(4):398-406. PubMed ID: 28164394
[TBL] [Abstract][Full Text] [Related]
7. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study.
Eliasson M; Asplund K; Nasic S; Rodu B
J Intern Med; 2004 Aug; 256(2):101-10. PubMed ID: 15257722
[TBL] [Abstract][Full Text] [Related]
8. Use of moist oral snuff (snus) and pancreatic cancer: Pooled analysis of nine prospective observational studies.
Araghi M; Rosaria Galanti M; Lundberg M; Lager A; Engström G; Alfredsson L; Knutsson A; Norberg M; Sund M; Wennberg P; Trolle Lagerros Y; Bellocco R; Pedersen NL; Östergren PO; Magnusson C
Int J Cancer; 2017 Aug; 141(4):687-693. PubMed ID: 28486772
[TBL] [Abstract][Full Text] [Related]
9. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease.
Yang F; Pedersen NL; Ye W; Liu Z; Norberg M; Forsgren L; Trolle Lagerros Y; Bellocco R; Alfredsson L; Knutsson A; Jansson JH; Wennberg P; Galanti MR; Lager ACJ; Araghi M; Lundberg M; Magnusson C; Wirdefeldt K
Int J Epidemiol; 2017 Jun; 46(3):872-880. PubMed ID: 27940486
[TBL] [Abstract][Full Text] [Related]
10. Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer.
Nordenvall C; Nilsson PJ; Ye W; Andersson TM; Nyrén O
Int J Cancer; 2013 Jan; 132(1):155-61. PubMed ID: 22492255
[TBL] [Abstract][Full Text] [Related]
11. The relationship of snus use to diabetes and allied conditions.
Lee PN; Thornton AJ
Regul Toxicol Pharmacol; 2017 Dec; 91():86-92. PubMed ID: 29061372
[TBL] [Abstract][Full Text] [Related]
12. Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37-year follow-up study.
Nordenvall C; Nilsson PJ; Ye W; Nyrén O
Int J Cancer; 2011 Jan; 128(1):157-65. PubMed ID: 20209500
[TBL] [Abstract][Full Text] [Related]
13. Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA).
Rasouli B; Andersson T; Carlsson PO; Grill V; Groop L; Martinell M; Midthjell K; Storm P; Tuomi T; Carlsson S
Diabet Med; 2017 Apr; 34(4):514-521. PubMed ID: 27353226
[TBL] [Abstract][Full Text] [Related]
14. No association between moist oral snuff (snus) use and oral cancer: pooled analysis of nine prospective observational studies.
Araghi M; Galanti MR; Lundberg M; Liu Z; Ye W; Lager A; Engström G; Alfredsson L; Knutsson A; Norberg M; Wennberg P; Lagerros YT; Bellocco R; Pedersen NL; Östergren PO; Magnusson C
Scand J Public Health; 2021 Dec; 49(8):833-840. PubMed ID: 32466721
[No Abstract] [Full Text] [Related]
15. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study.
Luo J; Ye W; Zendehdel K; Adami J; Adami HO; Boffetta P; Nyrén O
Lancet; 2007 Jun; 369(9578):2015-2020. PubMed ID: 17498797
[TBL] [Abstract][Full Text] [Related]
16. Snus use, smoking and survival among prostate cancer patients.
Wilson KM; Markt SC; Fang F; Nordenvall C; Rider JR; Ye W; Adami HO; Stattin P; Nyrén O; Mucci LA
Int J Cancer; 2016 Dec; 139(12):2753-2759. PubMed ID: 27582277
[TBL] [Abstract][Full Text] [Related]
17. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts.
Arefalk G; Hergens MP; Ingelsson E; Arnlöv J; Michaëlsson K; Lind L; Ye W; Nyrén O; Lambe M; Sundström J
Eur J Prev Cardiol; 2012 Oct; 19(5):1120-7. PubMed ID: 21828223
[TBL] [Abstract][Full Text] [Related]
18. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies.
Byhamre ML; Araghi M; Alfredsson L; Bellocco R; Engström G; Eriksson M; Galanti MR; Jansson JH; Lager A; Lundberg M; Östergren PO; Pedersen NL; Trolle Lagerros Y; Ye W; Wennberg P; Magnusson C
Int J Epidemiol; 2021 Jan; 49(6):2041-2050. PubMed ID: 33347584
[TBL] [Abstract][Full Text] [Related]
19. Do never smokers make up an increasing share of snus users as cigarette smoking declines? Changes in smoking status among male snus users in Norway 2003-15.
Lund KE; Vedøy TF; Bauld L
Addiction; 2017 Feb; 112(2):340-348. PubMed ID: 27741374
[TBL] [Abstract][Full Text] [Related]
20. Tobacco and type 2 diabetes: is the association explained by genetic factors?
Carlsson S; Kuja-Halkola R; Magnusson C; Lagerros YT; Andersson T
Int J Epidemiol; 2019 Jun; 48(3):926-933. PubMed ID: 30726916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
